BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10087967)

  • 21. Combined therapy with Fludarabine and cyclophosphamide in relapsed/resistant patients with B-cell chronic lymphocytic leukaemia and non-Hodgkin's lymphomas.
    Zaja F; Rogato A; Russo D; Marin L; Silvestri F; Baccarani M
    Eur J Haematol; 1997 Nov; 59(5):327-8. PubMed ID: 9414645
    [No Abstract]   [Full Text] [Related]  

  • 22. Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (non-Hodgkin's) lymphoma.
    Roberts JD; Smith MR; Feldman EJ; Cragg L; Millenson MM; Roboz GJ; Honeycutt C; Thune R; Padavic-Shaller K; Carter WH; Ramakrishnan V; Murgo AJ; Grant S
    Clin Cancer Res; 2006 Oct; 12(19):5809-16. PubMed ID: 17020988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia.
    Foran JM; Oscier D; Orchard J; Johnson SA; Tighe M; Cullen MH; de Takats PG; Kraus C; Klein M; Lister TA
    J Clin Oncol; 1999 May; 17(5):1574-9. PubMed ID: 10334546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fludarabine in the treatment of chronic lymphocytic leukemia and other lymphoproliferative disorders].
    Pawelski S
    Acta Haematol Pol; 1995; 26(3):263-8. PubMed ID: 8525771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of fludarabin in conjunction with other cytostatics in the treatment of non-Hodgkin lymphoma resistant to standard chemotherapy].
    Gershanovich ML; Tikhonova VV
    Vopr Onkol; 2004; 50(5):602-4. PubMed ID: 15715106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fludarabine: a review of its use in non-Hodgkin's lymphoma.
    Anderson VR; Perry CM
    Drugs; 2007; 67(11):1633-55. PubMed ID: 17661532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Phase II clinical study of SH L 573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia].
    Miyawaki S; Imamura M; Kobayashi S; Ohnishi K; Hodohara K; Mizoguchi H; Tomonaga M; Tango T; Ohno R
    Rinsho Ketsueki; 1999 Dec; 40(12):1236-44. PubMed ID: 10658476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II study of oral fludarabine phosphate in relapsed indolent B-Cell non-Hodgkin's lymphoma.
    Tobinai K; Watanabe T; Ogura M; Morishima Y; Ogawa Y; Ishizawa K; Minami H; Utsunomiya A; Taniwaki M; Terauchi T; Nawano S; Matsusako M; Matsuno Y; Nakamura S; Mori S; Ohashi Y; Hayashi M; Seriu T; Hotta T
    J Clin Oncol; 2006 Jan; 24(1):174-80. PubMed ID: 16330664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia.
    Boogaerts MA; Van Hoof A; Catovsky D; Kovacs M; Montillo M; Zinzani PL; Binet JL; Feremans W; Marcus R; Bosch F; Verhoef G; Klein M
    J Clin Oncol; 2001 Nov; 19(22):4252-8. PubMed ID: 11709569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fludarabine therapy in chronic lymphocytic leukemia (CLL).
    Keating MJ; Kantarjian H; Talpaz M; Redman J; McCredie KB
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):461-6. PubMed ID: 2464794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
    Willis CR; Goodrich A; Park K; Waselenko JK; Lucas M; Reese A; Diehl LF; Grever MR; Byrd JC; Flinn IW
    Ann Hematol; 2006 May; 85(5):301-7. PubMed ID: 16518606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fludarabine phosphate in lymphoma: an important new therapeutic agent.
    McLaughlin P; Robertson LE; Keating MJ
    Cancer Treat Res; 1996; 85():3-14. PubMed ID: 9043771
    [No Abstract]   [Full Text] [Related]  

  • 33. Potentiation of fludarabine cytotoxicity on non-Hodgkin's lymphoma by pentoxifylline and rituximab.
    Alas S; Bonavida B; Emmanouilides C
    Anticancer Res; 2000; 20(5A):2961-6. PubMed ID: 11062708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fludarabine phosphate. A new anticancer drug with significant activity in patients with chronic lymphocytic leukemia and in patients with lymphoma.
    Rodriguez G
    Invest New Drugs; 1994; 12(2):75-92. PubMed ID: 7532163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II trial of fludarabine monophosphate in patients with mantle-cell lymphomas.
    Decaudin D; Bosq J; Tertian G; Nedellec G; Bennaceur A; Venuat AM; Bayle C; Carde P; Bendahmane B; Hayat M; Munck JN
    J Clin Oncol; 1998 Feb; 16(2):579-83. PubMed ID: 9469344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fludarabine phosphate in the treatment of chronic lymphocytic leukemia: biology, clinical impact, and future directions.
    Robertson LE; Keating MJ
    Cancer Treat Res; 1993; 64():105-19. PubMed ID: 7680874
    [No Abstract]   [Full Text] [Related]  

  • 37. Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.
    Redman JR; Cabanillas F; Velasquez WS; McLaughlin P; Hagemeister FB; Swan F; Rodriguez MA; Plunkett WK; Keating MJ
    J Clin Oncol; 1992 May; 10(5):790-4. PubMed ID: 1373760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fludarabine phosphate for the treatment of low grade lymphoid malignancy.
    Whelan JS; Davis CL; Rule S; Ranson M; Smith OP; Mehta AB; Catovsky D; Rohatiner AZ; Lister TA
    Br J Cancer; 1991 Jul; 64(1):120-3. PubMed ID: 1713049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of advanced chronic lymphocytic leukemia by fludarabine. Results of a clinical phase-II study.
    Hiddemann W; Rottmann R; Wörmann B; Thiel A; Essink M; Ottensmeier C; Freund M; Büchner T; van de Loo J
    Ann Hematol; 1991 Jul; 63(1):1-4. PubMed ID: 1715191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.
    Keating MJ; Kantarjian H; O'Brien S; Koller C; Talpaz M; Schachner J; Childs CC; Freireich EJ; McCredie KB
    J Clin Oncol; 1991 Jan; 9(1):44-9. PubMed ID: 1702145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.